Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration

Clinical trial NCT02157077 · COMPLETED

Trial details

NCT number: NCT02157077
Sponsor: Centre Hospitalier Intercommunal Creteil
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Degeneration Wet Macular Degeneration Retinal Degeneration Retinal Diseases Eye Diseases

Start date: 2013-12-01
Primary completion: 2015-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.